Your browser doesn't support javascript.
loading
Early dissemination seeds metastasis in breast cancer.
Hosseini, Hedayatollah; Obradovic, Milan M S; Hoffmann, Martin; Harper, Kathryn L; Sosa, Maria Soledad; Werner-Klein, Melanie; Nanduri, Lahiri Kanth; Werno, Christian; Ehrl, Carolin; Maneck, Matthias; Patwary, Nina; Haunschild, Gundula; Guzvic, Miodrag; Reimelt, Christian; Grauvogl, Michael; Eichner, Norbert; Weber, Florian; Hartkopf, Andreas D; Taran, Florin-Andrei; Brucker, Sara Y; Fehm, Tanja; Rack, Brigitte; Buchholz, Stefan; Spang, Rainer; Meister, Gunter; Aguirre-Ghiso, Julio A; Klein, Christoph A.
Afiliação
  • Hosseini H; Experimental Medicine and Therapy Research, University of Regensburg, 93053 Regensburg, Germany.
  • Obradovic MMS; Experimental Medicine and Therapy Research, University of Regensburg, 93053 Regensburg, Germany.
  • Hoffmann M; Project group 'Personalized Tumour Therapy', Fraunhofer Institute for Toxicology und Experimental Medicine, 93053 Regensburg, Germany.
  • Harper KL; Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, Department of Oncological Sciences, Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
  • Sosa MS; Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, Department of Oncological Sciences, Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
  • Werner-Klein M; Institute of Immunology, University of Regensburg, 93053 Regensburg, Germany.
  • Nanduri LK; Experimental Medicine and Therapy Research, University of Regensburg, 93053 Regensburg, Germany.
  • Werno C; Project group 'Personalized Tumour Therapy', Fraunhofer Institute for Toxicology und Experimental Medicine, 93053 Regensburg, Germany.
  • Ehrl C; Experimental Medicine and Therapy Research, University of Regensburg, 93053 Regensburg, Germany.
  • Maneck M; Experimental Medicine and Therapy Research, University of Regensburg, 93053 Regensburg, Germany.
  • Patwary N; Experimental Medicine and Therapy Research, University of Regensburg, 93053 Regensburg, Germany.
  • Haunschild G; Experimental Medicine and Therapy Research, University of Regensburg, 93053 Regensburg, Germany.
  • Guzvic M; Experimental Medicine and Therapy Research, University of Regensburg, 93053 Regensburg, Germany.
  • Reimelt C; Experimental Medicine and Therapy Research, University of Regensburg, 93053 Regensburg, Germany.
  • Grauvogl M; Department of Statistical Bioinformatics, Institute of Functional Genomics, University of Regensburg, 93053 Regensburg, Germany.
  • Eichner N; Biochemistry Center Regensburg (BZR), Laboratory for RNA Biology, University of Regensburg, 93053 Regensburg, Germany.
  • Weber F; Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany.
  • Hartkopf AD; Department of Gynecology and Obstetrics, University of Tübingen, 72076 Tübingen, Germany.
  • Taran FA; Department of Gynecology and Obstetrics, University of Tübingen, 72076 Tübingen, Germany.
  • Brucker SY; Department of Gynecology and Obstetrics, University of Tübingen, 72076 Tübingen, Germany.
  • Fehm T; Department of Gynecology and Obstetrics, University of Düsseldorf, 40225 Düsseldorf, Germany.
  • Rack B; Department of Gynecology and Obstetrics, University Munich, 80337 Munich, Germany.
  • Buchholz S; Department of Gynecology and Obstetrics, University Medical Center Regensburg, 93053 Regensburg, Germany.
  • Spang R; Department of Statistical Bioinformatics, Institute of Functional Genomics, University of Regensburg, 93053 Regensburg, Germany.
  • Meister G; Biochemistry Center Regensburg (BZR), Laboratory for RNA Biology, University of Regensburg, 93053 Regensburg, Germany.
  • Aguirre-Ghiso JA; Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, Department of Oncological Sciences, Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
  • Klein CA; Experimental Medicine and Therapy Research, University of Regensburg, 93053 Regensburg, Germany.
Nature ; 540(7634): 552-558, 2016 Dec 22.
Article em En | MEDLINE | ID: mdl-27974799
ABSTRACT
Accumulating data suggest that metastatic dissemination often occurs early during tumour formation, but the mechanisms of early metastatic spread have not yet been addressed. Here, by studying metastasis in a HER2-driven mouse breast cancer model, we show that progesterone-induced signalling triggers migration of cancer cells from early lesions shortly after HER2 activation, but promotes proliferation in advanced primary tumour cells. The switch from migration to proliferation was regulated by increased HER2 expression and tumour-cell density involving microRNA-mediated progesterone receptor downregulation, and was reversible. Cells from early, low-density lesions displayed more stemness features, migrated more and founded more metastases than cells from dense, advanced tumours. Notably, we found that at least 80% of metastases were derived from early disseminated cancer cells. Karyotypic and phenotypic analysis of human disseminated cancer cells and primary tumours corroborated the relevance of these findings for human metastatic dissemination.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Nature Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Nature Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha